{"slug":"childhood-cancer","tag":"childhood-cancer","variants":["childhood-cancer"],"description":"No description yet","count":1,"kinds":{"technology":1},"related":[{"slug":"biological-ageing","tag":"biological-ageing","shared":1},{"slug":"late-effects","tag":"late-effects","shared":1},{"slug":"rejuvenation","tag":"rejuvenation","shared":1},{"slug":"survivorship","tag":"survivorship","shared":1}],"records":[{"id":"rejuv-age-frailty-and-late-effects","kind":"technology","name":"Frailty and late effects in survivors","route":"/technologies/rejuv-age-frailty-and-late-effects/","status":"established","tldr":"The clearest evidence that treatment ages people is not a laboratory marker, it is what happens to survivors decades later. In the St Jude Lifetime Cohort, one in eight women who had cancer as a child met the clinical definition of frailty at a mean age of 33, a rate usually seen after 65. Frailty predicted new chronic conditions and death."}]}